Compare · ISRG vs ZY
ISRG vs ZY
Side-by-side comparison of Intuitive Surgical Inc. (ISRG) and Zymergen Inc. (ZY): market cap, price performance, sector, and recent activity on the wire.
Summary
- ISRG operates in Health Care, while ZY operates in Industrials - the two are in different parts of the market.
- ISRG is the larger of the two at $97.09B, about 198.8x ZY ($488.5M).
- ISRG has hit the wire 4 times in the past 4 weeks while ZY has been quiet.
- ISRG has more recent analyst coverage (25 ratings vs 13 for ZY).
- Company
- Intuitive Surgical Inc.
- Zymergen Inc.
- Price
- $482.17+0.68%
- $2.44+2.10%
- Market cap
- $97.09B
- $488.5M
- 1M return
- +2.61%
- -
- 1Y return
- -6.26%
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2000
- 2021
- News (4w)
- 4
- 0
- Recent ratings
- 25
- 13
Intuitive Surgical Inc.
Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
Zymergen Inc.
Zymergen Inc. designs, engineers, and optimizes microbes for industrial applications in United States, Asia, and Europe. The company has a platform that treats the genome as a search space, to identify genetic changes that improve the economics for its customers' bio-based products for a range of industries, including chemicals and materials, agriculture, and pharmaceuticals. Zymergen's platform is used to discover novel molecules used to enable unique material properties. The company was incorporated in 2013 and is based in Emeryville, California.
Latest ISRG
- SEC Form 10-Q filed by Intuitive Surgical Inc.
- Intuitive Announces First Quarter Earnings
- Intuitive Surgical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- The Infrastructure Play Hiding in Plain Sight Across Cardiac Care
- Amendment: SEC Form SCHEDULE 13G/A filed by Intuitive Surgical Inc.
- Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems
- SEC Form DEFA14A filed by Intuitive Surgical Inc.
- SEC Form DEF 14A filed by Intuitive Surgical Inc.
- EVP & Chief Medical Officer Curet Myriam exercised 105 shares at a strike of $229.39 and sold $51,865 worth of shares (105 units at $493.95) (SEC Form 4)
- Intuitive Surgical upgraded by Citigroup with a new price target
Latest ZY
- SEC Form 15-12G filed by Zymergen Inc.
- SEC Form EFFECT filed by Zymergen Inc.
- SEC Form SC 13G/A filed by Zymergen Inc. (Amendment)
- SEC Form 4: Svf Excalibur (Cayman) Ltd disposed of 26,614,219 shares
- SEC Form 4: Flatley Jay T returned 144,789 shares to the company, closing all direct ownership in the company
- SEC Form 4: Chu Steven returned 50,000 shares to the company, closing all direct ownership in the company
- SEC Form 4: Peterson Sandra E returned 119,119 shares to the company, closing all direct ownership in the company
- SEC Form 4: Murdoch Travis returned 79,697 shares to the company, closing all direct ownership in the company
- SEC Form 4: Gorjanc Christine Marie returned 50,000 shares to the company, closing all direct ownership in the company
- SEC Form 4 filed by Sharma Rohit